BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Prognosis
32 results:

  • 1. Advances in Molecular Profiling and Developing Clinical Trials of CNS Germ Cell Tumors: Present and Future Directions.
    Takami H
    Curr Oncol Rep; 2022 Jan; 24(1):105-112. PubMed ID: 35059994
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Current Management of Refractory Germ Cell Tumors.
    Abughanimeh O; Teply BA
    Curr Oncol Rep; 2021 Jul; 23(9):101. PubMed ID: 34269906
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Preoperative Inflammation Markers and De Ritis Ratio in Predicting Clinical Presentation and prognosis of Patients with testicular Germ Cell Tumors.
    Olcucu MT; Karamik K; Yilmaz K; Okuducu Y; Cakir S; Ates M
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):1041-1046. PubMed ID: 33143824
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Active surveillance in stage 1 disease: standard of care independent of risk factors?
    Nason GJ; Leao R; Hamilton RJ
    Curr Opin Urol; 2020 Mar; 30(2):245-250. PubMed ID: 31834082
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study.
    Pozza C; Pofi R; Tenuta M; Tarsitano MG; Sbardella E; Fattorini G; Cantisani V; Lenzi A; Isidori AM; Gianfrilli D;
    Hum Reprod; 2019 Aug; 34(8):1389-1403. PubMed ID: 31532522
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in testicular Germ Cell Tumors.
    Schmidtova S; Kalavska K; Kucerova L
    Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Retroperitoneal lymph node dissection in the setting of elevated markers.
    Lakes J; Lusch A; Nini A; Albers P
    Curr Opin Urol; 2018 Sep; 28(5):435-439. PubMed ID: 30004909
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Biological basis and early clinical results of immunotherapy for cisplatin-resistant germ cell cancer.
    Oing C; Bokemeyer C
    Curr Opin Urol; 2018 Sep; 28(5):479-484. PubMed ID: 29957683
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Disease Characteristics and Treatment Outcome of testicular Germ Cell Tumors Treated with Platinum-Based Regimens.
    Sattar A; Masood M; Nisar H; Fatima I; Shahid AB
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):292-296. PubMed ID: 29615170
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Managing seminomatous and nonseminomatous germ cell tumors.
    Chahoud J; Zhang M; Shah A; Lin SH; Pisters LL; Tu SM
    Curr Opin Oncol; 2018 May; 30(3):181-188. PubMed ID: 29538040
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. testicular tumors in prepubescent patients.
    Maizlin II; Dellinger M; Gow KW; Goldin AB; Goldfarb M; Nuchtern JG; Langer M; Vasudevan SA; Doski JJ; Raval MV; Beierle EA
    J Pediatr Surg; 2018 Sep; 53(9):1748-1752. PubMed ID: 29102152
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. testicular germ cell tumor genomics.
    Woldu SL; Amatruda JF; Bagrodia A
    Curr Opin Urol; 2017 Jan; 27(1):41-47. PubMed ID: 27584029
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Metastatic surgery in testis cancer.
    Pfister D; Haidl F; Paffenholz P; Heidenreich A
    Curr Opin Urol; 2016 Nov; 26(6):590-5. PubMed ID: 27387962
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
    Göbel U; Calaminus G; Haas R; Teske C; Schönberger S; Schneider DT; Leuschner I; Harms D
    Klin Padiatr; 2014 Nov; 226(6-7):316-22. PubMed ID: 25431864
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [De novo urologic tumors in kidney transplant patients].
    Rodríguez Faba O; Breda A; Gausa L; Palou J; Villavicencio H
    Actas Urol Esp; 2015 Mar; 39(2):122-7. PubMed ID: 24996779
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The study of DNA methylation in urological cancer: present and future.
    Andrés G; Ashour N; Sánchez-Chapado M; Ropero S; Angulo JC
    Actas Urol Esp; 2013 Jun; 37(6):368-75. PubMed ID: 23643196
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. testicular germ cell tumors: biology and clinical update.
    Nallu A; Mannuel HD; Hussain A
    Curr Opin Oncol; 2013 May; 25(3):266-72. PubMed ID: 23549473
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pediatric genitourinary tumors.
    Buckley KS
    Curr Opin Oncol; 2011 May; 23(3):297-302. PubMed ID: 21460723
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Contemporary management of metastatic castration-resistant prostate cancer.
    Sonpavde G; Sternberg CN
    Curr Opin Urol; 2011 May; 21(3):241-7. PubMed ID: 21455038
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.
    Kollmannsberger C; Bokemeyer C
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):167-72. PubMed ID: 18685416
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.